Clinical Trial Update: Erythropoietin for Infants With Brain Injuries Due to Oxygen Deprivation at Birth [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating erythropoietin for newborn brain injury due to birth asphyxia; the current status is not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Birth Asphyxia
• Hypoxic-ischemic Encephalopathy

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Conditions: Asphyxia | Phase 1 | Status: UNKNOWN